Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular Biosystems completes Oralex Phase I trials

This article was originally published in Clinica

Executive Summary

Molecular Biosystems hopes to begin Phase II trials of its orally-administered abdominal ultrasound imaging agent, Oralex, this summer following completion of Phase I trials. The agent was more effective than water, the standard agent for this procedure, in displacing gas in the stomach and slowing the gastric emptying process, says MBI. The results are awaiting FDA review.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091852

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel